Association between interleukin-12 p40 subunit and risk of primary Sjögren's syndrome: a Mendelian randomization study.

Zuckerman, Benjamin P; Yang, Zijing; Warwick, Alasdair; Wincup, Chris; Russell, Mark; Galloway, James B; Zhao, Sizheng Steven

Zuckerman, Benjamin P; Yang, Zijing; Warwick, Alasdair; Wincup, Chris; Russell, Mark; Galloway, James B; Zhao, Sizheng Steven.

Afiliação

Zuckerman BP; Centre for Rheumatic Diseases, King's College London, London, UK.
Yang Z; Centre for Rheumatic Diseases, King's College London, London, UK.
Warwick A; Institute of Cardiovascular Science, University College London, UK.
Wincup C; NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, UK.
Russell M; Centre for Rheumatic Diseases, King's College London, London, UK.
Galloway JB; Centre for Rheumatic Diseases, King's College London, London, UK.
Zhao SS; Centre for Rheumatic Diseases, King's College London, London, UK.

Rheumatology (Oxford) ; 2024 Sep 02.

Article em En | MEDLINE | ID: mdl-39222420

Palavras-chave

Interleukin-12 (Up to 10); Mendelian Randomization; Sjögren's disease

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google